Efficacy and safety of telitacicept therapy in systemic lupus erythematosus with hematological involvement-Reference-Cited by-同舟云学术

Efficacy and safety of telitacicept therapy in systemic lupus erythematosus with hematological involvement

Published:2024-05-20 Issue:7 Volume:43 Page:2229-2236
ISSN:0770-3198
Container-title:Clinical Rheumatology
language:en
Short-container-title:Clin Rheumatol

Author:

Cheng Jirong^ORCID,Peng Yuanhong,Wu Qiurong,Wu Qian,He Jing,Yuan Guohua

Funder

National Key R&D Program of China

Beijing sci-Tech Program

National Natural Science Foundation of China

Publisher

Springer Science and Business Media LLC

Link

https://link.springer.com/content/pdf/10.1007/s10067-024-06992-7.pdf

Reference36 articles.

1. Pan L, Lu MP, Wang JH, Xu M, Yang SR (2020) Immunological pathogenesis and treatment of systemic lupus erythematosus. World J Pediatr 16:19–30. https://doi.org/10.1007/s12519-019-00229-3

2. Rekvig OP (2020) Autoimmunity and SLE: factual and semantic evidence-based critical analyses of definitions, etiology, and pathogenesis. Front Immunol 11:569234. https://doi.org/10.3389/fimmu.2020.569234

3. Justiz VA, Goyal A, Varacallo M (2023) Systemic lupus erythematosus. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2023 Jan

4. Alarcón GS, Mcgwin GJ, Roseman JM, Uribe A, Fessler BJ, Bastian HM, Friedman AW, Baethge B, Vilá LM, Reveille JD (2004) Systemic lupus erythematosus in three ethnic groups. XIX. Natural history of the accrual of the American College of Rheumatology criteria prior to the occurrence of criteria diagnosis. Arthritis Rheum 51:609–615. https://doi.org/10.1002/art.20548

5. Hochberg MC (1997) Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 40:1725. https://doi.org/10.1002/art.1780400928